BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 23957698)

  • 1. Association study of chemokine (C-C motif) ligand 5 gene polymorphism and papillary thyroid cancer.
    Kwon KH; Lee YC; Chung JH; Eun YG
    J Invest Surg; 2013 Dec; 26(6):319-24. PubMed ID: 23957698
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Associations between promoter polymorphism -106A/G of interleukin-11 receptor alpha and papillary thyroid cancer in Korean population.
    Eun YG; Shin IH; Kim MJ; Chung JH; Song JY; Kwon KH
    Surgery; 2012 Feb; 151(2):323-9. PubMed ID: 21982075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin 22 polymorphisms and papillary thyroid cancer.
    Eun YG; Shin IH; Lee YC; Shin SY; Kim SK; Chung JH; Kwon KH
    J Endocrinol Invest; 2013 Sep; 36(8):584-7. PubMed ID: 23448944
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between a promoter polymorphism (rs2192752, -1028A/C) of interleukin 1 receptor, type I (IL1R1) and location of papillary thyroid carcinoma in a Korean population.
    Park SW; Kim MK; Kwon KH; Kim J
    Int J Immunogenet; 2012 Dec; 39(6):501-7. PubMed ID: 22594576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Fas-associated via death domain promoter polymorphism (rs10898853, -16C/T) as a risk factor for papillary thyroid cancer.
    Eun YG; Chung DH; Kim SW; Lee YC; Kim SK; Kwon KH
    Eur Surg Res; 2014; 52(1-2):1-7. PubMed ID: 24434721
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Single nucleotide polymorphisms of the Fas gene are associated with papillary thyroid cancer.
    Eun YG; Lee YC; Kim SK; Chung JH; Kwon KH; Park IS
    Auris Nasus Larynx; 2015 Aug; 42(4):326-31. PubMed ID: 25824544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association Between Genetic Polymorphisms in the Promoter Regions of Let-7 and Risk of Papillary Thyroid Carcinoma: A Case-Control Study.
    Wang Y; Wei T; Xiong J; Chen P; Wang X; Zhang L; Gao L; Zhu J
    Medicine (Baltimore); 2015 Oct; 94(43):e1879. PubMed ID: 26512603
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between x-ray repair cross-complementing group 3 (XRCC3) genetic polymorphisms and papillary thyroid cancer susceptibility in a Chinese Han population.
    Yuan K; Huo M; Sun Y; Wu H; Chen H; Wang Y; Fu R
    Tumour Biol; 2016 Jan; 37(1):979-87. PubMed ID: 26264616
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between microRNA polymorphisms and papillary thyroid cancer susceptibility.
    Dong G; Zhang R; Xu J; Guo Y
    Int J Clin Exp Pathol; 2015; 8(10):13450-7. PubMed ID: 26722556
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PDGFRA promoter polymorphisms are associated with the risk of papillary thyroid cancer.
    Kim MJ; Kim SK; Park HJ; Chung DH; Park HK; Lee JS; Kwon KH; Chung JH
    Mol Med Rep; 2012 May; 5(5):1267-70. PubMed ID: 22327316
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association study of integrins beta 1 and beta 2 gene polymorphism and papillary thyroid cancer.
    Eun YG; Kim SK; Chung JH; Kwon KH
    Am J Surg; 2013 Jun; 205(6):631-5. PubMed ID: 23388428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of the miR-149 Rs2292832 polymorphism with papillary thyroid cancer risk and clinicopathologic characteristics in a Chinese population.
    Wei WJ; Lu ZW; Li DS; Wang Y; Zhu YX; Wang ZY; Wu Y; Wang YL; Ji QH
    Int J Mol Sci; 2014 Nov; 15(11):20968-81. PubMed ID: 25405731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of Toll-like receptor 2 polymorphisms with papillary thyroid cancer and clinicopathologic features in a Korean population.
    Kim MK; Park SW; Kim SK; Park HJ; Eun YG; Kwon KH; Kim J
    J Korean Med Sci; 2012 Nov; 27(11):1333-8. PubMed ID: 23166414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Are the SNPs of NKX2-1 associated with papillary thyroid carcinoma in the Han population of Northern China?
    Ai L; Yu Y; Liu X; Wang C; Shi J; Sun H; Yu Q
    Front Med; 2014 Mar; 8(1):113-7. PubMed ID: 24452548
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A genetic association analysis of polymorphisms, rs2282695 and rs12373539, in the FOSB gene and papillary thyroid cancer.
    Han SA; Song JY; Min SY; Park WS; Kim MJ; Chung JH; Kwon KH
    Exp Ther Med; 2012 Sep; 4(3):519-523. PubMed ID: 23181129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Confirmation of papillary thyroid cancer susceptibility loci identified by genome-wide association studies of chromosomes 14q13, 9q22, 2q35 and 8p12 in a Chinese population.
    Wang YL; Feng SH; Guo SC; Wei WJ; Li DS; Wang Y; Wang X; Wang ZY; Ma YY; Jin L; Ji QH; Wang JC
    J Med Genet; 2013 Oct; 50(10):689-95. PubMed ID: 23847140
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polymorphism of IGF1R is associated with papillary thyroid carcinoma in a Korean population.
    Cho SH; Kim SK; Kwon E; Park HJ; Kwon KH; Chung JH
    J Interferon Cytokine Res; 2012 Sep; 32(9):401-6. PubMed ID: 22909219
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between single-nucleotide polymorphisms of BRAF and papillary thyroid carcinoma in a Chinese population.
    Zhang Q; Song F; Zheng H; Zhu X; Song F; Yao X; Zhang L; Chen K
    Thyroid; 2013 Jan; 23(1):38-44. PubMed ID: 22973979
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association Study of FOS-Like Antigen-2 Promoter Polymorphisms With Papillary Thyroid Cancer in Korean Population.
    Kim SW; Kim CD; Chung JH; Kwon KH
    Clin Exp Otorhinolaryngol; 2014 Mar; 7(1):42-6. PubMed ID: 24587880
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of the oncostatin m receptor gene polymorphisms with papillary thyroid cancer in the korean population.
    Hong IK; Eun YG; Chung DH; Kwon KH; Kim DY
    Clin Exp Otorhinolaryngol; 2011 Dec; 4(4):193-8. PubMed ID: 22232715
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.